03.04.2020 14:16:00

Mycronic Postpones the Annual General Meeting

STOCKHOLM, April 3, 2020 /PRNewswire/ -- Due to the prevailing uncertainty created by the spread of the coronavirus, the Board of Directors of Mycronic AB (publ) has decided to postpone the Annual General Meeting to a later date.

The Annual General Meeting was originally scheduled to take place on May 7, 2020 at Vasateatern, Vasagatan 19 in Stockholm.

Mycronic AB (publ) will publish a new notice to the Annual General Meeting no later than four weeks prior to the new date. The Annual General Meeting will at the latest be held on June 30, 2020, in accordance with existing legislation.

The information in this press release was published on April 3, 2020 at 2:00 p.m.

About Mycronic

Mycronic AB is a high-tech company engaged in the development, manufacture and marketing of production equipment with high precision and flexibility requirements for the electronics industry. Mycronic headquarters are located in Täby, north of Stockholm and the Group has subsidiaries in China, France, Germany, Japan, the Netherlands, Singapore, South Korea, United Kingdom and the United States. Mycronic is listed on NASDAQ Stockholm. www.mycronic.com.

For additional information, please contact:
Anders Lindqvist
President and CEO
Tel: +46-8-638-52-00
anders.lindqvist@mycronic.com

Tobias Bülow
Director Investor Relations
Tel: +46-734-018-216
tobias.bulow@mycronic.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/mycronic-ab/r/mycronic-postpones-the-annual-general-meeting,c3080256

The following files are available for download:

https://mb.cision.com/Main/10432/3080256/1223495.pdf

PDF

 

Analysen zu Mycronic ABmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Mycronic AB 34,94 0,98% Mycronic AB